Global Drug Makers Face Pricing Pressure as China Targets Affordable Healthcare
Global drug makers are confronting intensified pricing pressure in China as Beijing expands its volume‑based procurement scheme and pushes affordable healthcare through deep discounts. While innovative therapies listed on the national reimbursement drug list (NRDL) gain market volume, mature off‑patent products face price cuts exceeding 70%. Companies such as AstraZeneca, Eli Lilly and Roche reported modest growth in China, but the overall environment remains challenging, especially with a newly announced 100% U.S. tariff on patented pharmaceuticals.
Telehealth Abortion Will Remain Available for Now, After a Federal Judge's Ruling
A federal judge in Louisiana granted a stay on a lawsuit challenging the FDA's 2023 rule that permits telehealth prescribing of the abortion pill mifepristone. The decision keeps medication abortions available nationwide while the agency completes a safety review, which...
Study: Improving Healthcare 'Just as Critical' As Cutting Emissions in Fight Against Air Pollution
A new Lancet study finds that improving access to quality healthcare is as vital as cutting emissions for reducing premature deaths caused by air pollution. Researchers modelled global mortality and showed that strengthening health systems could prevent millions of deaths,...
Feds Pump $48M Into New Health R&D Centre
The Canadian federal government is allocating $48 million CAD (≈$35 million USD) to Providence Healthcare’s Clinical Support & Research Centre (CSRC) in Vancouver, creating an advanced innovation hub. The hub will house a Clinical Trials Unit, an XR‑enabled Simulation Centre, a Health...
ED Serving Double the Patients It Was Designed For
The emergency department at Michael Garron Hospital in Toronto is now treating more than 300 patients a day—double the 150‑patient capacity it was built for 30 years ago. Annual visits jumped to about 107,000, far exceeding the original design target...
Rethinking the Microbiology Workflow with Smarter Tools for Faster Answers and Less Waste
Bruker unveiled an integrated microbiology platform that combines rapid identification, antimicrobial susceptibility testing, same‑day strain typing and next‑generation sequencing analytics. The MALDI Biotyper can analyze up to 600 isolates per hour on a 96‑spot plate, while the IR Biotyper delivers...
Protect Yourself From Rising Medicare Fraud
Medicare beneficiaries face escalating fraud schemes as the Financial Crimes Enforcement Network (FinCEN) issues a new advisory urging vigilance. Expert Jae Oh stresses that fraud typically starts with stolen personal data, making beneficiaries the first line of defense. He recommends...
Phone Follow-Ups Smoothe Transitions Home
A Fraser Health study of more than 7,000 high‑risk patients found that nurse‑led telephone follow‑ups 48 hours after discharge reduced short‑term emergency department visits. The intervention lowered 7‑day ED returns by roughly 28% and 30‑day returns by 12% after adjusting...
Quebec Drops Many ER Stats From Public Dashboard
Since Santé Québec assumed control of Quebec's health‑care dashboard in February, it has stripped away most emergency‑room (ER) performance targets and key overcrowding indicators that were previously public. The removal eliminates visual cues such as the red‑dotted line that showed...
Virtual ERs Working for Rural Alberta: Study
Alberta Health Services' Virtual Emergency Physician (VEP) program, launched in early 2025, connects off‑site emergency doctors with rural emergency departments lacking on‑site coverage. In the first six months, virtual physicians covered 229 shifts (about 3,000 hours), treated roughly 1,150 low‑acuity...
Donors Provide $5.75M to Cross-Sector Think-Tank
McGill University has launched the Initiative for Transforming Healthcare (ITH), a cross‑sector think‑tank aimed at tackling Canada’s mounting health‑system pressures. The effort unites the Desautels Faculty of Management, the Faculty of Medicine and Health Sciences, and the Max Bell School...
FirstHX Offers Ambient Scribe that Doesn’t Guess
FirstHx Corp. launched ARIS, a next‑generation ambient scribe that injects clinician‑grade patient history into the AI workflow before the encounter begins. By gathering structured data from patients ahead of time, ARIS provides the contextual foundation that eliminates the hallucinations typical...
Engineered Immunosuppressive Dendritic Cells Protect Against Cardiac Remodelling
Researchers engineered fibroblast‑activation‑protein (FAP)‑targeted immunosuppressive dendritic cells (iCDCs) that co‑express CTLA4‑Ig, PD‑L1 and IL‑10. In mouse myocardial infarction, ischemia‑reperfusion and pressure‑overload models, a single iCDC infusion markedly improved ejection fraction, reduced ventricular dilation and fibrosis, and extended survival. The therapy...
What to Watch: FDA's FY 2027 Budget
The FDA’s FY 2027 budget, a $7.2 billion request, outlines several policy‑driven proposals. It seeks new statutory authority to label misleading direct‑to‑consumer drug ads as misbranded, and introduces an optional “Expedited IND” pathway to accelerate Phase 1 trials using validated pre‑clinical data. The...
Novo Nordisk's Explosive Wegovy Pill Launch Draws a New Wave of Patients Into GLP-1 Weight Loss Treatment
Novo Nordisk’s oral Wegovy pill launched in January and has already generated over 600,000 prescriptions within three months, attracting tens of thousands of new patients who previously avoided GLP‑1 injections. The drug is priced at $149‑$299 per month, markedly lower...
FinCEN Advisory Mandates Expansion of SAR Reporting in Healthcare Context
FinCEN issued a March 30, 2026 Healthcare Fraud Advisory (FIN‑2026‑A001) that adds 24 new, healthcare‑specific red flags for banks to monitor. The guidance targets three core fraud schemes: shell companies posing as providers, false or inflated Medicare/Medicaid claims, and laundering of illicit...
Court Orders FDA To Provide Update On Mifepristone Review Before Midterms
A Louisiana district judge ordered the FDA to issue an update on its Risk Evaluation and Mitigation Strategy (REMS) review for the abortion medication mifepristone within six months. The mandate arrives as the Trump administration faces pressure to clarify its...
Nursing Homes, Providers Mixed Over Proposed 2.4% Bump In Fiscal 2027 Pay
The Centers for Medicare & Medicaid Services (CMS) has proposed a 2.4% increase in Medicare reimbursement rates for skilled nursing facilities (SNFs) for fiscal year 2027. The nursing‑home lobby praised the move as a practical boost to Medicare payments, while...
Q&A: The Slack Channels Powering CMS' Interoperability Framework
The Centers for Medicare & Medicaid Services (CMS) has launched an Interoperability Framework that relies on public Slack channels to bring together a broad coalition of health‑tech firms, consultants, and government agencies. By inviting any interested party to join as...
What Are the Health Impacts of Sea-Level Rise, and Who Should Pay?
The Lancet Commission on sea‑level rise health and justice was launched to examine how rising oceans threaten Pacific health systems, with 62% of facilities within 500 metres of the coast. Experts warn that saltwater intrusion, water‑borne disease, displacement and food insecurity...
![[Comment] Life at the Water's Edge: A Lancet Commission on Sea-Level Rise, Health, and Justice](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/f7b862f66dee1270bd326b6a9b7e8859.webp)
[Comment] Life at the Water's Edge: A Lancet Commission on Sea-Level Rise, Health, and Justice
The Lancet Commission’s latest comment warns that accelerating sea‑level rise will reshape daily life for hundreds of millions, with up to 410 million people projected to live below the high‑tide line by 2100. It details how rising waters amplify disease transmission,...
Low-Field MRI Revolutionizes Global Dementia Care
Low‑field MRI scanners, priced under $100,000 and free of cryogenic cooling, are emerging as affordable, portable alternatives to traditional high‑field systems. Clinical studies across multiple continents demonstrate 85% sensitivity for early‑stage dementia markers such as hippocampal atrophy. The technology enables...
Scientists Achieve Major Breakthrough in Safe, Reversible Male Contraception
A multinational research team announced a breakthrough in male contraception: a non‑hormonal, reversible pill that achieved 95% efficacy in Phase‑III trials. The compound, which temporarily blocks sperm maturation, proved safe across a diverse cohort with no reported hormonal side effects....
Attendees Value Networking Opportunities at HIMSS26
HIMSS26’s TV floor interviews reveal that attendees consider networking the event’s biggest draw. Health‑IT professionals cite meeting peers, vendors, and former collaborators as a core reason for attending. The conference’s large, diverse audience creates fertile ground for both new connections...
'Incredibly Worrisome': Concerns for Sick Refugees without Medicare
A growing number of asylum seekers in Australia are denied Medicare, leaving them without essential preventive care. Visa categories such as bridging visas often exclude families, and eligibility can lapse during lengthy residency processing. The story of Raj, who cannot...
Same Services, Sicker Individuals, Less Time: Daily Frustrations with Medicare Advantage as Acuity Rises in Nursing Homes
Medicare Advantage plans are forcing nursing homes to deliver the same level of care to sicker residents in dramatically shorter stays, compressing average skilled‑nursing episodes from about 21 days to as little as 7‑14 days. Methodist Retirement Communities (MRC) reports...
Proposed Federal Budget Includes Major Cuts to Healthcare Funding
The Trump administration’s 2027 budget proposal, released on April 3, calls for sweeping cuts to federal health programs, including a $5 billion reduction for the National Institutes of Health and a $129 million cut to the Agency for Healthcare Research and Quality. Overall,...
Trends in Manufacturer Coupons for Biologics: Decline in Use Despite Higher Per-Claim Value
Manufacturer-sponsored coupons for biologics have declined from 18.0% of patients in 2017 to 13.9% in 2024, even as the median coupon amount per claim rose from $60 to $90. The drop is most pronounced for obesity and diabetes therapies, while...
Q&A: Obesity Medicine 2026 Will Emphasize ‘Treating the Whole Picture’
The Obesity Medicine Association’s annual conference will take place April 10‑12 in San Diego, centered on the theme “The Heart of Obesity Care.” The event highlights a holistic view of cardiometabolic health, linking heart disease, diabetes, liver disease, and other...
Long-Term Cardiac Amyloidosis Survival Benefits Seen in Extension Acoramidis Trial
The open‑label extension of the ATTRibute‑CM trial demonstrated that the transthyretin stabilizer acoramidis (Attruby) delivers sustained survival benefits out to 54 months in patients with cardiac amyloidosis. Participants who began acoramidis early and remained on therapy showed markedly lower all‑cause...
Leg Amputee Forced to Wait Two Months for Rehabilitation Services
Phillip Norris, a 66‑year‑old radio announcer from Inverell, NSW, underwent a leg amputation in December and spent two months navigating a fragmented rehabilitation pathway. After multiple hospital transfers and a 2,000‑km travel burden, he finally received a prosthetic leg at...
CMS to Host 7th Annual HL7 FHIR Connectathon in July
The Centers for Medicare & Medicaid Services (CMS) will host its seventh annual HL7 Fast Healthcare Interoperability Resources (FHIR) Connectathon from July 14‑16, 2026. The virtual event will bring together interoperability leaders, implementers and innovators to conduct hands‑on testing of...
Is Vitamin D Associated with Lower Levels of Alzheimer’s Biomarkers?
A longitudinal study of 793 adults tracked vitamin D levels at an average age of 39 and brain‑scan biomarkers 16 years later. Participants with serum vitamin D above 30 ng/mL showed significantly lower tau protein accumulation, a key Alzheimer’s marker, while no link...
Heart Attack, Stroke Risk Can Double From Irregular Bedtimes, Sleeping Less than 8 Hours
A Finnish cohort study of 3,231 middle‑aged adults found that people who keep irregular bedtimes and sleep fewer than eight hours a night face nearly double the risk of major cardiovascular events over the next decade. Researchers used a week...
Insmed Discontinues Development of Skin Condition Drug After Mid-Stage Study Miss
Insmed announced it will discontinue development of brensocatib, its investigational therapy for hidradenitis suppurativa, after the drug failed to meet the primary efficacy endpoint in a mid‑stage trial. The study aimed to reduce painful nodules in patients with the chronic...
Darwin Midwife's $1.1 Million Government Contract Under Review
The Northern Territory government is reviewing a $1.1 million contract granted to Claire Marks, a midwife whose registration is limited to supervised practice. The funding supports her firm Midwives in Darwin, created to plug a void after the collapse of private...
FDA Approves First Generic Dapagliflozin to Reduce HF Hospitalization Risk in Type 2 Diabetes
The FDA has approved the first generic dapagliflozin tablets, expanding access to the SGLT2 inhibitor that lowers heart‑failure hospitalizations in type‑2 diabetes. The generics match the branded product’s safety and efficacy profile, offering a lower‑cost alternative to Farxiga. This approval...
Hints of a Mortality Benefit With TTVR at 2 Years TRISCEND II
The TRISCEND II trial shows transcatheter tricuspid valve replacement (TTVR) remains safe and improves quality of life at two years. A post‑hoc crossover analysis suggests a mortality advantage for patients receiving the Edwards Evoque device versus those who never received TTVR. While...
CDC Finds Nearly Half of U.S. Adults Get Recommended Amount of Physical Activity
The CDC’s April 7 data brief reports that 47.2% of U.S. adults met the federal aerobic‑activity guideline in 2024, up from previous years. Men (52.3%) were more likely than women (42.4%) to achieve the target. Compliance rose with higher education,...
ASHE’s 2026 Health Care Facilities Innovation Conference Set for August
The American Society for Health Care Engineering (ASHE) announced that registration is now open for its 2026 Health Care Facilities Innovation Conference, scheduled for August 2‑5 in Minneapolis. The event, formerly known as the ASHE Annual Conference & Technical Exhibition, is...
Lifestyle Interventions as a Pillar of Breast Cancer Risk Reduction With Douglas Marks, MD
In a Managed Care Cast interview, NYU oncologist Douglas Marks highlighted how diet, regular exercise, and reduced alcohol intake can substantially lower a woman's risk of developing breast cancer. He cited robust epidemiologic data linking these lifestyle changes to measurable...
AlpE Combo: New Tuberculosis Treatment Breakthrough
An international research team has introduced AlpE, a novel combination of Alpibectir and ethionamide, that dramatically shortens tuberculosis therapy and boosts efficacy against drug‑resistant strains. Alpibectir, a new class of mycobacterial enzyme inhibitor, works synergistically with ethionamide to disrupt cell‑wall...
Kansas Greenlights Laser Surgery by Optometrists
Kansas Governor Laura Kelly signed legislation on March 13 allowing optometrists to perform laser capsulotomy and laser trabeculoplasty, expanding their drug‑prescribing authority to all non‑injection routes and adding minor surgical procedures. The change makes Kansas the 15th state to grant optometric...
Navigating the Frontiers of Advanced Therapeutics and Operational Excellence
In 2026 the biopharma sector is juggling rapid advances in emerging modalities—viral vectors, multispecific antibodies and nucleic‑acid therapies—with heightened operational discipline. Companies are deploying patient‑derived xenograft models, 3‑D organoids and AI‑enhanced spectral flow cytometry to de‑risk next‑gen immunotherapies. Manufacturing focus...
Next Reconciliation Bill to Target Healthcare
Congressional leaders are drafting a new budget reconciliation bill, slated for possible enactment by July, that will target healthcare spending to help fund roughly $64 billion for the Department of Homeland Security and $200 billion for the ongoing Iran conflict. The bill...
Front-of-Package Labels Are Already Shaping Shopper Behaviour
Canada’s Health Canada launched mandatory front‑of‑package (FOP) nutrition warning labels on Jan. 1. Early data shows 56% of shoppers are aware of the symbols, while 57% say the warnings would affect their buying choices. Price remains the dominant purchase driver for...
Welltower Buys Palm Beach County Assisted Living Facility for $87M
Welltower, the senior‑living REIT, acquired The Arbor at Lake Worth in Florida for $87.2 million, a price roughly 36 percent higher than the $64 million paid two years earlier. The 366,000‑square‑foot campus houses 377 assisted‑living units, a recreation center, auditorium and a nursing...
Trump’s VA Budget Request Tops $488 Billion for Fiscal 2027
The White House’s FY2027 budget request proposes a 7.7% increase for the Department of Veterans Affairs, lifting its total to a record $488 billion. The plan allocates $205.6 billion in discretionary spending and $282.6 billion in mandatory funds, funding new facilities, a medical...
Did Eli Lilly Just Strike Another Gold Mine?
Eli Lilly announced a $1.5 billion acquisition of a biotech portfolio centered on orexin‑targeting therapeutics. The deal adds late‑stage candidates for insomnia, narcolepsy and metabolic disorders to Lilly’s central‑nervous‑system pipeline. Analysts estimate the combined market for orexin drugs could surpass $10 billion by...
What’s Familiar in Health Tech’s Q1 Funding Totals
Health‑tech funding surged in Q1, highlighted by Whoop’s $575 million Series G round that lifted its valuation into the multibillion‑dollar range. Smaller but notable deals included OpenEvidence, eMed, Talkiatry and Alphabet’s Verily, each securing tens of millions to expand data, telehealth, AI‑driven...